10:03 AM EST, 11/06/2025 (MT Newswires) -- Edgewise Therapeutics' ( EWTX ) shares were up more than 3% in recent Thursday trading after the company reported a Q3 net loss of $0.39 per diluted share, widening from $0.34 the preceding quarter.

Four analysts polled by FactSet expected a loss of $0.40 per share.

No revenue was reported for the quarter ended sept. 30, as expected.

Price: 17.80, Change: +0.43, Percent Change: +2.45